Navigating the landscape of end-of-life care and access to medications like this drug in New South Wales, NSW, requires a careful understanding of the complex legal framework. Currently, Pentobarbital does not have a approved place on the Pharmaceutical Benefits Scheme (PBS) and is therefore not commonly prescribed by clinical professionals. Its ap